Related Experiment Video
Updated: Feb 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease
Erhan Tatar1, Fatih Kircelli, Ercan Ok
1Ege University School of Medicine, Division on Nephrology, 35100 Bornova, Izmir, Turkey. etatar@hotmail.com
Insights
Thyroid hormone metabolism dysfunction contributes to cardiovascular disease in chronic kidney disease patients by affecting atherosclerosis and arterial stiffness. Understanding these mechanisms is key to managing heart health in kidney patients.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular disease (CVD) risk.
- Accelerated atherosclerosis and arterial stiffness are primary drivers of CVD in CKD.
- Thyroid hormone metabolism dysfunction is implicated in CVD pathogenesis.
Purpose of the Study:
- To explore the mechanistic links between thyroid hormone metabolism and CVD in CKD.
- To review current literature on this association.
Main Methods:
- Review of existing scientific literature.
- Analysis of mechanistic pathways.
Main Results:
- Thyroid dysfunction impacts cardiac function, vascular resistance, and lipid profiles.
- It also exacerbates inflammation and endothelial dysfunction.
- These factors collectively contribute to atherosclerosis and arterial stiffness in CKD.
Conclusions:
- Thyroid hormone metabolism plays a critical role in CKD-associated CVD.
- Targeting thyroid dysfunction may offer therapeutic strategies for cardiovascular complications in CKD patients.
Abstract:
Accelerated atherosclerosis and arterial stiffness are the two leading causes of increased cardiovascular disease in patients with chronic kidney disease. Dysfunctional thyroid hormone metabolism has been suggested to play a role in atherosclerosis and arterial stiffness. Changes in cardiac contractility and output, myocardial oxygen demand, systemic and peripheral vascular resistance, blood pressure and lipid profile, increased inflammatory burden and endothelial dysfunction may be responsible for thyroid hormone-related cardiovascular disease. This article focuses on the mechanistic insights of this association and provides a concise review of the current literature.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

